These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21906210)

  • 1. Impact of triplicate testing on HIV genotypic tropism prediction in routine clinical practice.
    Symons J; Vandekerckhove L; Paredes R; Verhofstede C; Bellido R; Demecheleer E; van Ham PM; van Lelyveld SF; Stam AJ; van Versendaal D; Nijhuis M; Wensing AM
    Clin Microbiol Infect; 2012 Jun; 18(6):606-12. PubMed ID: 21906210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High concordance of genotypic coreceptor prediction in plasma-viral RNA and proviral DNA of HIV-1 subtype C: implications for use of whole blood DNA in resource-limited settings.
    Gupta S; Neogi U; Srinivasa H; Shet A
    J Antimicrob Chemother; 2013 Sep; 68(9):2003-6. PubMed ID: 23633683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA study group.
    Svicher V; Alteri C; Montano M; D'Arrigo R; Andreoni M; Angarano G; Antinori A; Antonelli G; Allice T; Bagnarelli P; Baldanti F; Bertoli A; Borderi M; Boeri E; Bon I; Bruzzone B; Callegaro AP; Capobianchi MR; Carosi G; Cauda R; Ceccherini-Silberstein F; Clementi M; Chirianni A; Colafigli M; D'Arminio Monforte A; De Luca A; Di Biagio A; Di Nicuolo G; Di Perri G; Di Pietro M; Di Santo F; Fabeni L; Fadda G; Galli M; Gennari W; Ghisetti V; Giacometti A; Gori C; Gori A; Gulminetti R; Leoncini F; Maffongelli G; Maggiolo F; Manca G; Gargiulo F; Martinelli C; Maserati R; Mazzotta F; Meini G; Micheli V; Monno L; Mussini C; Narciso P; Nozza S; Paolucci S; Pal G; Parisi S; Parruti G; Pignataro AR; Pollicita M; Quirino T; Re MC; Rizzardini G; Santangelo R; Scaggiante R; Sterrantino G; Turriziani O; Vatteroni ML; Vecchi L; Viscoli C; Vullo V; Zazzi M; Lazzarini A; Perno CF;
    New Microbiol; 2012 Jan; 35(1):17-25. PubMed ID: 22378549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concordance between HIV-1 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNA.
    Verhofstede C; Brudney D; Reynaerts J; Vaira D; Fransen K; De Bel A; Seguin-Devaux C; De Wit S; Vandekerckhove L; Geretti AM
    HIV Med; 2011 Oct; 12(9):544-52. PubMed ID: 21518222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV co-receptor tropism prediction remains stable over time in treatment-naïve patients.
    Philip KE; Macartney MJ; Conibear TC; Smith CJ; Marshall N; Johnson MA; Haque T; Webster DP
    Int J STD AIDS; 2016 Jun; 27(7):576-80. PubMed ID: 25999168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lowest X4 Geno2Pheno false-positive rate is associated with greater CD4 depletion in HIV-1 infected patients.
    Santoro MM; Armenia D; Fabeni L; Santoro M; Gori C; Forbici F; Svicher V; Bertoli A; Dori L; Surdo M; Balestra E; Palamara G; Girardi E; Angarano G; Andreoni M; Narciso P; Antinori A; Ceccherini-Silberstein F; Perno CF
    Clin Microbiol Infect; 2012 Aug; 18(8):E289-98. PubMed ID: 22681969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonists.
    Seclén E; Garrido C; González Mdel M; González-Lahoz J; de Mendoza C; Soriano V; Poveda E
    J Antimicrob Chemother; 2010 Jul; 65(7):1486-92. PubMed ID: 20427374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of genotypic prediction of HIV-1 tropism using population sequencing of replicates.
    Ferreira JL; Coelho LP; Rodrigues R; Cabral GB; Cavalcanti Jde S; Guimaraes PM; Brigido LF
    J Virol Methods; 2012 Feb; 179(2):325-9. PubMed ID: 22138669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotypic tropism of antiretroviral-treated patients with drug resistant HIV-1.
    Parczewski M; Leszczyszyn-Pynka M; Urbanska A; Bander D; Boron-Kaczmarska A
    J Med Virol; 2011 Nov; 83(11):1869-75. PubMed ID: 21915859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro.
    Svicher V; Balestra E; Cento V; Sarmati L; Dori L; Vandenbroucke I; D'Arrigo R; Buonomini AR; Van Marck H; Surdo M; Saccomandi P; Mostmans W; Aerssens J; Aquaro S; Stuyver LJ; Andreoni M; Ceccherini-Silberstein F; Perno CF
    Antiviral Res; 2011 Apr; 90(1):42-53. PubMed ID: 21349294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of genotypic tropism prediction tests compared with in vitro co-receptor usage in HIV-1 primary isolates of diverse subtypes.
    Delgado E; Fernández-García A; Vega Y; Cuevas T; Pinilla M; García V; Sánchez M; González M; Sánchez AM; Thomson MM; Pérez-Álvarez L
    J Antimicrob Chemother; 2012 Jan; 67(1):25-31. PubMed ID: 22010208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics of HIV tropism under suppressive antiretroviral therapy: implications for tropism testing in subjects with undetectable viraemia.
    Seclén E; Del Mar González M; De Mendoza C; Soriano V; Poveda E
    J Antimicrob Chemother; 2010 Jul; 65(7):1493-6. PubMed ID: 20488982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-based V3 genotypic tropism assay: a retrospective analysis using screening samples from the A4001029 and MOTIVATE studies.
    McGovern RA; Thielen A; Mo T; Dong W; Woods CK; Chapman D; Lewis M; James I; Heera J; Valdez H; Harrigan PR
    AIDS; 2010 Oct; 24(16):2517-25. PubMed ID: 20736814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV population genotypic tropism testing and its clinical significance.
    Obermeier M; Symons J; Wensing AM
    Curr Opin HIV AIDS; 2012 Sep; 7(5):470-7. PubMed ID: 22832711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with proviral DNA HIV-1 tropism in antiretroviral therapy-treated patients with fully suppressed plasma HIV viral load: implications for the clinical use of CCR5 antagonists.
    Soulié C; Fourati S; Lambert-Niclot S; Malet I; Wirden M; Tubiana R; Valantin MA; Katlama C; Calvez V; Marcelin AG
    J Antimicrob Chemother; 2010 Apr; 65(4):749-51. PubMed ID: 20150182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-receptor switch during HAART is independent of virological success.
    Saracino A; Monno L; Cibelli DC; Punzi G; Brindicci G; Ladisa N; Tartaglia A; Lagioia A; Angarano G
    J Med Virol; 2009 Dec; 81(12):2036-44. PubMed ID: 19856465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two genotypic algorithms to determine HIV-1 tropism.
    Soulié C; Derache A; Aimé C; Marcelin AG; Carcelain G; Simon A; Katlama C; Calvez V
    HIV Med; 2008 Jan; 9(1):1-5. PubMed ID: 18199166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 tropism: a comparison between RNA and proviral DNA in routine clinical samples from Chilean patients.
    Ferrer P; Montecinos L; Tello M; Tordecilla R; Rodríguez C; Ferrés M; Pérez CM; Beltrán C; Guzmán MA; Afani A
    Virol J; 2013 Oct; 10():318. PubMed ID: 24165156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep-Sequencing Analysis of the Dynamics of HIV-1 Quasiespecies in Naive Patients during a Short Exposure to Maraviroc.
    Cascajero A; Rastrojo A; Díez-Fuertes F; Hernández-Novoa B; Aguado B; Moreno S; Alcami J; Pérez-Olmeda M
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29563289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy.
    Meini G; Rossetti B; Bianco C; Ceccherini-Silberstein F; Di Giambenedetto S; Sighinolfi L; Monno L; Castagna A; Rozera G; D'Arminio Monforte A; Zazzi M; De Luca A;
    J Antimicrob Chemother; 2014 Mar; 69(3):735-41. PubMed ID: 24155059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.